Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach.
Journal Information
Full Title: Front Cardiovasc Med
Abbreviation: Front Cardiovasc Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Cardiac & Cardiovascular Systems
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest GM: Fulltime employee and shareholder of Abbott Laboratories. CF: Consulting: Abbott, FujiRebio, Quidel:Ortho, Roche Diagnostics, Siemens. Speaker: Pathfast. Grants/contracts as PI: Abbott, FujiRebio, Quidel:Ortho, Roche Siemens, NIH. Adjudication committee: Siemens, Tosoh. Patent: #10509044, Methods for assessing differential risk for developing heart failure. AB: Advisory board: Astra-Zeneca, DSMB: CTI Biopharma. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
"The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025